Tobacco Harm Reduction and the Veterans America Keeps Failing

A Population Being Left Behind

Veterans use tobacco at rates significantly higher than the general population. The VA's own data puts cigarette use among veterans at roughly 25 percent, compared to around 14 percent for civilians. Smokeless tobacco use is higher still in certain service branches. These are not numbers that exist in a vacuum — they track with the specific stressors of military service, the culture of unit cohesion where tobacco use has historically been a social ritual, and the limited options available to people managing the psychological weight of what combat and deployment actually do to a person.

The standard public health response to this data has been, for decades, the same response it applies to everyone else: cessation programs, nicotine replacement therapy, counseling, pharmacological aids. The message, essentially: quit. That message has had limited effectiveness across the general population. Among veterans, whose relationship with tobacco is often bound up with identity, community, and the coping mechanisms that got them through experiences most Americans will never have, the message has done even less.

What Harm Reduction Actually Means

The tobacco harm reduction framework starts from a different premise. Some people will use nicotine. They have chosen to. Telling them to stop has not worked. Given that reality, the question becomes: how do we reduce the harm associated with their nicotine use as much as possible? And the answer the evidence points to is: by moving them away from combusted tobacco toward products with substantially lower risk profiles.

The data on this is not ambiguous. Public Health England — not exactly a free-market libertarian institution — concluded in 2015 that vaping is approximately 95 percent less harmful than smoking. Heated tobacco products show meaningful reductions in harmful chemical delivery compared to cigarettes. Snus — the Swedish oral tobacco product that has been used as a case study in harm reduction for decades — is associated with substantially lower rates of lung cancer and cardiovascular disease compared to cigarettes. Sweden has the lowest smoking-attributable mortality in Europe. That's not coincidence. It's the result of a population that shifted to lower-risk products rather than simply quitting.

For veterans who cannot or will not quit nicotine, access to accurate information about these alternatives is not a minor convenience. It's a potentially life-extending opportunity that the current regulatory and public health framework systematically obscures.

The Regulatory Obstacle

The FDA's tobacco regulatory framework, established under the Family Smoking Prevention and Tobacco Control Act of 2009, requires that any new tobacco or nicotine product demonstrate it is "appropriate for the protection of public health" before it can be marketed. In practice, this has created a regulatory environment where innovative lower-risk products face years of expensive premarket review while combusted cigarettes — the most lethal products in the category — remain freely available because they were grandfathered in.

This is perverse. The regulatory architecture effectively protects the most harmful products from competition by the least harmful ones. A veteran trying to switch from cigarettes to a lower-risk alternative encounters regulatory barriers that didn't exist when he picked up his first pack. The system's priorities are not oriented toward his health. They are oriented toward process, toward political cover, toward the comfort of an anti-tobacco establishment that conflates all nicotine use with cigarette smoking and refuses to engage honestly with the risk differential.

The people paying the price for this regulatory dysfunction are not policy analysts or FDA bureaucrats. They're veterans with lung damage and cardiovascular disease who were never told in plain terms that better options existed or might have been available if the regulatory path had been clearer.

What Serving Those Who Serve Actually Looks Like

Genuine commitment to veteran health requires honest engagement with the tobacco harm reduction evidence. It means the VA should be actively providing information about reduced-risk alternatives to veterans who use tobacco and cannot or will not quit. It means Congress should be pushing the FDA to rationalize its premarket review process so that it doesn't systematically disadvantage lower-risk products. It means the public health establishment needs to stop letting perfect — total cessation — be the enemy of substantially better.

These are not radical positions. They are positions supported by the scientific literature and adopted by health agencies in multiple peer countries. The gap between what the evidence supports and what American health policy delivers on this issue is itself a kind of abandonment — one more way the country talks about serving veterans while actually leaving them to navigate broken systems alone.